Skip to main content
Premium Trial:

Request an Annual Quote

Bernhard Spiess

Castle Biosciences has appointed Bernhard Spiess as chief operating officer. Bernhard most recently served as vice president of product management for both clinical chemistry and infectious diseases at Beckman Coulter. He spent 23 years working at Beckman Coulter and played key leadership roles in the development and commercialization of various platforms. Earlier in his career, Bernhard worked for Sanofi Diagnostics Pasteur and Abbott Diagnostics.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.